Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas N Wight

Showing results (21-30 of 209) with videos related to

Pageof 21
Sort By:
Journal of Cell Science|June 22, 2002
Alterations in the lens capsule contribute to cataractogenesis in SPARC-null miceQi Yan, John I Clark, Thomas N Wight, et al.
The Journal of Biological Chemistry|April 11, 2014
Expression of versican V3 by arterial smooth muscle cells alters tumor growth factor β (TGFβ)-, epidermal growth factor (EGF)-, and nuclear factor κB (NFκB)-dependent signaling pathways, creating a microenvironment that resists monocyte adhesionInkyung Kang, Dong Won Yoon, Kathleen R Braun, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 17, 2005
Antioxidants inhibit the ability of lysophosphatidylcholine to regulate proteoglycan synthesisMary Y Chang, Chang-Yeop Han, Thomas N Wight, et al.
Journal of Lipid Research|January 17, 2002
Arterial smooth muscle cell proteoglycans synthesized in the presence of glucosamine demonstrate reduced binding to LDLLisa R Tannock, Peter J Little, Thomas N Wight, et al.
Atherosclerosis|June 10, 2004
Removal of heparan sulfate by heparinase treatment inhibits FGF-2-dependent smooth muscle cell proliferation in injured rat carotid arteriesMichael G Kinsella, Colleen Irvin, Michael A Reidy, et al.
Current Opinion in Lipidology|September 14, 2004
The accumulation of specific types of proteoglycans in eroded plaques: a role in coronary thrombosis in the absence of ruptureFrank D Kolodgie, Allen P Burke, Thomas N Wight, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 17, 2007
Early human atherosclerosis: accumulation of lipid and proteoglycans in intimal thickenings followed by macrophage infiltrationYutaka Nakashima, Hiroshi Fujii, Shinji Sumiyoshi, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|January 13, 2018
Proteoglycans as Immunomodulators of the Innate Immune Response to Lung InfectionInkyung Kang, Mary Y Chang, Thomas N Wight, et al.
Journal of Lipid Research|August 19, 2003
Statin-exposed vascular smooth muscle cells secrete proteoglycans with decreased binding affinity for LDLC Daniel Meyers, Lisa R Tannock, Thomas N Wight, et al.
Pharmacological Reviews|June 25, 2009
Extracellular matrix molecules: potential targets in pharmacotherapyHannu Järveläinen, Annele Sainio, Markku Koulu, et al.
Pageof 21

Showing results (21-30 of 209) with videos related to

Sort By:
Pageof 21
Journal of Cell Science|June 22, 2002
Alterations in the lens capsule contribute to cataractogenesis in SPARC-null miceQi Yan, John I Clark, Thomas N Wight, et al.
The Journal of Biological Chemistry|April 11, 2014
Expression of versican V3 by arterial smooth muscle cells alters tumor growth factor β (TGFβ)-, epidermal growth factor (EGF)-, and nuclear factor κB (NFκB)-dependent signaling pathways, creating a microenvironment that resists monocyte adhesionInkyung Kang, Dong Won Yoon, Kathleen R Braun, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 17, 2005
Antioxidants inhibit the ability of lysophosphatidylcholine to regulate proteoglycan synthesisMary Y Chang, Chang-Yeop Han, Thomas N Wight, et al.
Journal of Lipid Research|January 17, 2002
Arterial smooth muscle cell proteoglycans synthesized in the presence of glucosamine demonstrate reduced binding to LDLLisa R Tannock, Peter J Little, Thomas N Wight, et al.
Atherosclerosis|June 10, 2004
Removal of heparan sulfate by heparinase treatment inhibits FGF-2-dependent smooth muscle cell proliferation in injured rat carotid arteriesMichael G Kinsella, Colleen Irvin, Michael A Reidy, et al.
Current Opinion in Lipidology|September 14, 2004
The accumulation of specific types of proteoglycans in eroded plaques: a role in coronary thrombosis in the absence of ruptureFrank D Kolodgie, Allen P Burke, Thomas N Wight, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 17, 2007
Early human atherosclerosis: accumulation of lipid and proteoglycans in intimal thickenings followed by macrophage infiltrationYutaka Nakashima, Hiroshi Fujii, Shinji Sumiyoshi, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|January 13, 2018
Proteoglycans as Immunomodulators of the Innate Immune Response to Lung InfectionInkyung Kang, Mary Y Chang, Thomas N Wight, et al.
Journal of Lipid Research|August 19, 2003
Statin-exposed vascular smooth muscle cells secrete proteoglycans with decreased binding affinity for LDLC Daniel Meyers, Lisa R Tannock, Thomas N Wight, et al.
Pharmacological Reviews|June 25, 2009
Extracellular matrix molecules: potential targets in pharmacotherapyHannu Järveläinen, Annele Sainio, Markku Koulu, et al.
Pageof 21